Chromosome 17 Centromere Duplication and Responsiveness to Anthracycline-Based Neoadjuvant Chemotherapy in Breast Cancer()()

Human epidermal growth factor receptor 2 (HER2) and topoisomerase II alpha (TOP2A) genes have been proposed as predictive biomarkers of sensitivity to anthracycline chemotherapy. Recently, chromosome 17 centromere enumeration probe (CEP17) duplication has also been associated with increased responsi...

Descripción completa

Detalles Bibliográficos
Autores principales: Tibau, Ariadna, López-Vilaró, Laura, Pérez-Olabarria, Maitane, Vázquez, Tania, Pons, Cristina, Gich, Ignasi, Alonso, Carmen, Ojeda, Belén, Ramón y Cajal, Teresa, Lerma, Enrique, Barnadas, Agustí, Escuin, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Neoplasia Press 2014
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212250/
https://www.ncbi.nlm.nih.gov/pubmed/25379022
http://dx.doi.org/10.1016/j.neo.2014.08.012

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4212250/
https://www.ncbi.nlm.nih.gov/pubmed/25379022
http://dx.doi.org/10.1016/j.neo.2014.08.012

Ejemplares similares